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ABSTRACT
OBJECTIVE
To examine the associations of blood pressure with all
cause mortality and cause specific mortality at three
years among oldest old people in China.
DESIGN
Community based, longitudinal prospective study.
SETTING
2011 and 2014 waves of the Chinese Longitudinal
Healthy Longevity Survey, conducted in 22 Chinese
provinces.
PARTICIPANTS
4658 oldest old individuals (mean age 92.1 years).
MAIN OUTCOME MEASURES
All cause mortality and cause specific mortality
assessed at three year follow-up.
RESULTS
1997 deaths were recorded at three year follow-up. U
shaped associations of mortality with systolic blood
pressure, mean arterial pressure, and pulse pressure
were identified; values of 143.5 mm Hg, 101 mm Hg,
and 66 mm Hg conferred the minimum mortality risk,
respectively. After adjustment for covariates, the U
shaped association remained only for systolic blood
pressure (minimum mortality risk at 129 mm Hg).
Compared with a systolic blood pressure value of 129
mm Hg, risk of all cause mortality decreased for values
lower than 107 mm Hg (from 1.47 (95% confidence
interval 1.01 to 2.17) to 1.08 (1.01 to 1.17)), and
increased for values greater than 154 mm Hg (from
1.08 (1.01 to 1.17) to 1.27 (1.02 to 1.58)). In the

What is already known on this topic
Hypertension and hypotension are well established risk factors of morbidity and
survival in middle aged or younger elderly people, while the association weakens
with age
For people aged 80 years and older, previous studies regarding the role of blood
pressure in all cause mortality and cause specific mortality have generated
conflicting results

What this study adds
Among a study sample group of oldest old people in China, systolic blood
pressure showed a U shaped association with three year all cause mortality
Higher values of systolic blood pressure predicted a higher risk of cardiovascular
mortality, and lower values predicted a higher risk of non-cardiovascular
mortality
The present paradigm of “the lower the better” in blood pressure regulation does
not apply to oldest old people, and optimal blood pressure might need revisiting
after age 80 years
the bmj | BMJ 2018;361:k2158 | doi: 10.1136/bmj.k2158

cause specific analysis, compared with a middle range
of systolic blood pressure (107-154 mm Hg), higher
values (>154 mm Hg) were associated with a higher
risk of cardiovascular mortality (adjusted hazard
ratio 1.51 (95% confidence interval 1.12 to 2.02));
lower values (<107 mm Hg) were associated with a
higher risk of non-cardiovascular mortality (1.58 (1.26
to 1.98)). The U shaped associations remained in
sensitivity and subgroup analyses.
CONCLUSIONS
This study indicates a U shaped association between
systolic blood pressure and all cause mortality at
three years among oldest old people in China. This
association could be explained by the finding that
higher systolic blood pressure predicted a higher
risk of death from cardiovascular disease, and that
lower systolic blood pressure predicted a higher
risk of death from non-cardiovascular causes. These
results emphasise the importance of revisiting
blood pressure management or establishing specific
guidelines for management among oldest old
individuals.

Introduction
Hypertension and hypotension are well established
risk factors of morbidity and survival before the age
of 80 years1 2; however, the contribution of those
conditions to all cause mortality weakens with ageing.
Whether this attenuation is a natural ageing process
or a pathological process that should to be intervened
remains unclear. The number of oldest old people
(aged ≥80 years) will be the fastest growing group
between now and 2050; therefore, it is important to
determine whether a significant association exists
between blood pressure and all cause mortality or
cause specific mortality in this age group. However,
conflicting results have been reported—especially
regarding systolic blood pressure and diastolic blood
pressure. Most observational studies have found
that changes in systolic or diastolic blood pressure
predicted higher mortality risk,3-11 even showing a
J or U shaped association12-14; however, some have
failed to detect significant association between blood
pressure and mortality.15 16 One meta-analysis showed
that higher systolic blood pressure predicted increased
mortality risk in all age groups, including oldest old
people.17 Furthermore, some experimental studies
have found that the treatment of isolated systolic
hypertension prevented stroke and heart failure;
but findings regarding prevention against all cause
mortality have been conflicting for people aged over
80 years.18-21
1
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Methods
Study cohort
Participants were recruited from the sixth wave (2011)
Chinese Longitudinal Healthy Longevity Survey
(CLHLS). A multistage cluster sampling approach was
used in this prospective, longitudinal, community
based study. We initially selected 22 provinces of
China (Beijing, Tianjin, Chongqing, Shanghai, Anhui,
Fujian, Guangdong, Guangxi, Hubei, Hunan, Henan,
Hebei, Heilongjiang, Liaoning, Jiangxi, Jiangsu, Jilin,
Shandong, Shaanxi, Shanxi, Sichuan, and Zhejiang);
we then randomly selected half the cities or counties
in these provinces.
All centenarians were interviewed in the 801
randomly selected cities or counties. Nearby
individuals (eg, in the selected street or village, or
in the selected city or county) were invited to be
investigated to match with each centenarian. These
matched individuals included younger elderly people
(aged 65-79 years), octogenarians, and nonagenarians
of predefined sex and age. The predefined sex and age
were in accordance with the centenarians’ randomly
assigned code numbers. This process ensured that the
numbers of randomly selected men and women were
comparable in the three age groups (65-79, 80-89, 9099 years). A more detailed description of the CLHLS
has been published elsewhere.25 Based on systematic
assessments of the randomness of attrition, credibility
2

and validity of the measurement scale, and accuracy
of reported age, the quality of the data for this study
was high.25 26
In all, 7328 elderly individuals were initially
included in the 2011 CLHLS. We excluded 2670
participants because they were younger elderly (≤79
years; n=2437), had incorrect death dates (n=43), or
were lacking blood pressure values (n=190). Finally,
4658 oldest old participants met the inclusion criteria
(2001 octogenarians, 1832 nonagenarians, and 825
centenarians; fig S1). A structured questionnaire
was used by a trained staff member from the county
Centers for Disease Control and Prevention to conduct
interviews. The information was collected from proxy
respondents, usually close family member or spouse, if
participants were unable to answer questions.
During the three year study period, 247 (5.3%)
participants were lost to follow-up (fig S1). The
participants’ survival status and date of death were
collected during the follow-up survey in 2014.
Information about death was ascertained and affirmed
by the close family member or village doctor of the
participant. Participants who could not be found or
contacted were designated as lost to follow-up.27 A
supplementary phone interview was conducted to
obtain information about antihypertensive treatment
in participants who self reported hypertension and
about cause specific mortality (cardiovascular v
non-cardiovascular) mortality in decedents. We used
ICD-10 (international classification of diseases, 10th
revision) to assess participants’ underlying cause of
death from cardiovascular disease (codes I00-I78)
or ischaemic heart disease (I20-I25). In all, 339
(28.4%) of 1195 patients with hypertension were
successfully followed up; details of cause of death
for 1088 (54.5%) participants were successfully
obtained. A statistical analysis of cardiovascular
and non-cardiovascular mortality is in the online
supplemental material.

Measurement and calculation of blood pressure
After participants had rested for at least five
minutes, research assistants took two measurements
of blood pressure on the right arm by mercury
sphygmomanometer (upper arm type; Yuyue, Jiangsu,
China). Korotkoff phase I was designated for the
systolic blood pressure values, phase V for the diastolic
blood pressure values. For bedbound participants,
blood pressure measurements were obtained in a
recumbent position. For further analyses, the mean
value was calculated with the two measurements
(pulse pressure=systolic blood pressure−diastolic
blood pressure; mean arterial pressure=(systolic blood
pressure+(2×diastolic blood pressure))÷3.
Assessment of covariates
Covariates were obtained by use of a structured
questionnaire. One section included sociodemographic
characteristics, comprising details of age, sex,
educational background, residence, marital status,
and economic income. The other section dealt with
doi: 10.1136/bmj.k2158 | BMJ 2018;361:k2158 | the bmj
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The following limitations with previous studies need
to be addressed:3-21
• The number of oldest old participants was limited
(<1000) in most studies. Most participants
were octogenarians and nonagenarians, with
centenarians under-represented.
• Most studies focused on specific populations or high
risk populations (eg, patients with hypertension);
studies on community based populations were
lacking.
• No linear or curvilinear associations were examined
by Cox models with penalised splines,22 which is a
valid approach for determining the shapes of the
association.
• No previous studies focused on the role of mean
arterial pressure; very few studies investigated pulse
pressure,7 which may be more salient blood pressure
indexes for mortality in this age group.23 24
• Most studies were implemented in developed
countries (Finland, Japan, Netherlands, Spain,
Sweden, United States), while research in developing
countries is very limited regarding the potential role
of blood pressure in mortality among this age group.
In the present community based study, we aimed to
deal with some of these existing gaps, by examining
the role of blood pressure in all cause mortality or
cause specific mortality among 4658 oldest old people
during a three year follow-up. We used Cox models
with penalised splines in our primary analyses and
accounted for several important confounding factors,
including clinical diseases, frailty, and functional
impairment.

RESEARCH

Statistical analysis
We used the Kaplan-Meier method to calculate all
cause mortality. We determined the survival time for
decedents as the period between the baseline survey
and death; censoring was performed at three years
the bmj | BMJ 2018;361:k2158 | doi: 10.1136/bmj.k2158

for surviving participants or those lost to follow-up.
We compared the characteristics between surviving
and deceased participants and between those lost to
follow-up and those successfully followed up, using
univariate Cox models for continuous variables and
the log rank test for categorical variables.
To examine the non-linear or irregular shape of
the hazard functions, we used Cox models with
penalised splines using non-parametric smoothers. We
calculated the hazard function for the i-th participant
in the j-th group as32:
λj,i (t) = λj,0(t) exp (Zi(t)βz + s(Xi(t),dfi))
Where λj,0=unspecified underlying hazard function;
βz=vector of parameters for covariate Zi(t), and
s(Xi(t),dfi)=penalised splines of covariates with the
corresponding degree of freedom (df).
With this model, we used the penalised
partial likelihood to estimate the parameters; we
selected penalised splines as smoothers (or spline
functions).32-34 We performed Cox models with
penalised splines twice. To determine whether linear
terms or flexible spline terms should be used in further
analyses, we examined the association of a continuous
variable (eg, blood pressure, age, educational
background, and body mass index) with mortality in
the univariate Cox models with penalised splines. If
the association between a continuous variable and
mortality was linear, we used linear terms for that
variable in further analyses using multivariate Cox
models with penalised splines. If the association
between a continuous variable and mortality was nonlinear, we used flexible spline terms for that variable
in further analyses using multivariate Cox models with
penalised splines.
We found the association of age (years), time spent in
education (years), and body mass index with mortality
to be linear (fig S2), while the associations of systolic
blood pressure, diastolic blood pressure, mean arterial
pressure, and pulse pressure with mortality were nonlinear (fig S3). Therefore, we used linear terms for age,
educational background, and body mass index; we
used flexible spline terms for systolic blood pressure,
diastolic blood pressure, mean arterial pressure, and
pulse pressure when performing multivariate Cox
models with penalised splines. Based on the corrected
Akaike information criterion, we selected the degree of
freedom as 3 for systolic blood pressure, diastolic blood
pressure, mean arterial pressure, and pulse pressure;
this method had been considered as the most reliable,
flexible criterion for fitting penalised splines in Cox
models.35 In final Cox models with penalised splines,
we made adjustments for: sex, age (as a linear term),
marital status, educational background (as a linear
term), residence, economic income, current smoking,
current alcohol consumption, cognitive impairment,
restriction on activities of daily living, poor visual
function body mass index (as a linear term), central
obesity, diabetes mellitus, cardiovascular disease,
stroke and other cerebrovascular diseases, respiratory
disease, cancer, and frailty.
3
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health characteristics; it covered smoking, drinking,
activities of daily living, visual function, cognition,
body mass index, waist circumference, and self
reported diseases diagnosed by a doctor—for instance,
diabetes mellitus, stroke and other cerebrovascular
diseases, cardiovascular disease, respiratory disease,
and cancer.
Residence was categorised as urban (city residence)
or rural (town or countryside residence). Marital status
was categorised as “not in marriage” if a participant
had never married or was widowed or divorced and
“in marriage” if a participant was currently married.
Economic income was classified as “high” and
“medium or low” by the question “Compared with
other locals, how do you think about your economic
position?” Current smoking practice and alcohol
consumption habits were assessed by self report based
on the questions “Do you currently smoke?” and “Do
you currently drink alcohol?”
Visual function was classified as “good” or “poor”
according to whether participants were able to
identify the break in the image of a circle held before
them. A non-stretchable tape was used to measure
waist circumference with the participant lightly
clothed; measurement was made between the iliac
crest and the lowest rib. Central obesity was defined
as a waist circumference at least 80 cm for women
and at least 85 cm for men. Body mass index was
calculated as bodyweight (kg) divided by squared
body height (m2). We defined cognitive impairment
as a mini-mental status examination score lower
than 24. Restriction in activities of daily living
was defined as a participant being dependent in
toileting, bathing, indoor activities, dressing, eating,
or continence. We defined comorbidity as 0 or at
least 1 according to the number of diseases (stroke
and other cerebrovascular diseases, cardiovascular
disease, diabetes mellitus, respiratory disease, and
cancer) that the participant had.
Frailty was defined by the study of osteoporotic
fractures index.28 The index included three
components: underweight (body mass index<18.5);
participants having trouble standing up from a chair
without the assistance of arms; and a positive response
to the question “Over the last 6 months, have you been
limited in activities because of a health problem?,”
indicating reduced energy level. We categorised frailty
in three states: frail (two or three components); prefrail (one component); and robust (no components),
which showed good ability for biological age among
Chinese elderly people.29 Overall, few data for the
covariates were missing (<3%): fewer than 1% of the
data were missing for any single variable, and we did
multiple imputation methods for the correction of
missing data in covariates.30 31
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Fig 1 | Associations of blood pressure with three year all cause mortality in study population of Chinese oldest old
people, in Cox models with penalised splines after adjustment. Lines=estimated hazard ratio of systolic blood
pressure (129 mm Hg reference), diastolic blood pressure (80 mm Hg), mean arterial pressure (90 mm Hg), and pulse
pressure (57.5 mm Hg) for risk of three year all cause mortality; dotted lines=95% confidence intervals; df=degrees
of freedom

4

Hg and 100 mm Hg for mean arterial pressure, and 50
mm Hg and 65 mm Hg for pulse pressure. Accordingly,
considering blood pressure as a continuous variable,
we stratified the participants into three categories
(lower, middle, and higher) based on the Cox models
with penalised splines (systolic blood pressure <107,
107-154, and >154 mm Hg, diastolic blood pressure
<70, 70-90, and >90 mm Hg, mean arterial pressure
<80, 80-100, and >100 mm Hg, and pulse pressure
<50, 50-65, and >65 mm Hg).36-38
We then used the Cox proportional hazards models
with and without the above covariates to estimate

Hazard ratio for all cause mortality

Cox models with penalised splines showed a
statistically significant U shaped association for systolic
blood pressure with three year all cause mortality.
Participants with 129 mm Hg systolic blood pressure
had the minimum mortality risk based on the estimated
parameters of penalised splines after adjustment (fig 1,
fig 2). Compared with individuals having 129 mm Hg
systolic blood pressure, the risk of all cause mortality
at three years was significantly higher in participants
with systolic blood pressure lower than 107 mm Hg
or higher than 154 mm Hg (P<0.05; fig 1, fig 2). The
Cox models with penalised splines showed U shaped
associations for diastolic blood pressure, mean arterial
pressure, and pulse pressure with mortality after
adjustment (fig 1); however, the associations were
not statistically significant. Based on the estimated
parameters of penalised splines after adjustment, the
minimum mortality was around 80 mm Hg, 90 mm Hg,
and 57.5 mm Hg for diastolic blood pressure, mean
arterial pressure, and pulse pressure, respectively
(fig 1).
Unlike with systolic blood pressure, we were unable
to identify the two other points with statistically
significant differences in all cause mortality compared
with study participants having 80 mm Hg diastolic
blood pressure, 90 mm Hg mean arterial pressure, and
57.5 mm Hg pulse pressure (fig 1). Thus, in line with
previous publications, we defined these two points (for
classifying lower, middle, and higher groups) as 70 mm
Hg and 90 mm Hg for diastolic blood pressure, 80 mm

2.0
1.5
1.0
0.5
0

80

90 100 110 120 130 140 150 160 170 180 190
Systolic blood pressure (mm Hg)

Fig 2 | Hazard ratio (95% CI) for three year all cause
mortality at different levels of systolic blood pressure
(80-190 mm Hg) in Cox models with penalised splines
after adjustment (129 mm Hg reference), in study
population of Chinese oldest old people
doi: 10.1136/bmj.k2158 | BMJ 2018;361:k2158 | the bmj
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Sensitivity and subgroup analyses
To clarify the role of participants lost to follow-up in
the associations, we did sensitivity analyses for such
participants censored at two time points: baseline
(0 years) and the midpoint of follow-up (1.5 years).
To examine the possibility that excessively higher or
lower blood pressure values could have been caused by
acute disease resulting in increased mortality, we also
conducted sensitivity analyses by excluding deaths in
the first year.
Some socioeconomic factors, functional status,
and morbidity could confound the association of
blood pressure with mortality. Thus, we investigated
interactions between these factors and blood pressure,
and we conducted subgroup analyses among:
• Octogenarians, nonagenarians, and centenarians
• Urban and rural residents
• Participants in marriage and not in marriage
• Participants with and without comorbidities
• Participants with and without a self reported
hypertension history
• Participants taking or not taking anti-hypertensive
treatment
• Participants with and without restrictions on
activities of daily living
• Robust, pre-frail, and frail participants.
We used SAS version 9.3 (SAS Institute) to conduct
statistical analyses and R version 3.4.2 (R foundation
for Statistical Computing) to conduct Cox models with
penalised splines.
Patient involvement
None of the participants was involved in the
questionnaire design, biological measurements, or
outcome measures; they were likewise not involved
in the design, recruitment, and implementation of the
study. Furthermore, all participants or their relatives
were informed of the systolic and diastolic blood
pressure results and use of the data for research in this
study. There were no plans to disseminate the study
results to participants.
Results
Participant characteristics
The mean participant age was 92.1 years at baseline;
57.4% (2675/4658) were female. During the followup of three years, 1997 participants died and 2414
survived (mortality rate 44.2%; table 1 and online
supplementary materials).
the bmj | BMJ 2018;361:k2158 | doi: 10.1136/bmj.k2158

Association of blood pressure with all cause
mortality
The results of the Cox models with penalised splines
revealed U shaped associations of systolic blood
pressure (P<0.001), mean arterial pressure (P=0.002),
and pulse pressure (P=0.002) with three year all cause
mortality. We saw no significant linear (P=0.38) or
non-linear (P=0.12) associations between diastolic
blood pressure and mortality before adjustment. We
identified the inflection points of the U shaped curve,
indicating minimum mortality risk, at 143.5 mm Hg for
systolic blood pressure, 101 mm Hg for mean arterial
pressure, and 66 mm Hg for pulse pressure (fig S3).
However, after adjustment for confounding factors,
the U shaped association with three year all cause
mortality disappeared for mean arterial pressure
(P=0.49) and pulse pressure (P=0.14), but remained
for systolic blood pressure (P=0.035). The systolic
blood pressure value that conferred the minimum
mortality risk was 129 mm Hg (fig 1, fig 2). Compared
with participants with value of 129 mm Hg, those with
a lower (<107 mm Hg) or higher (>154 mm Hg) value
had a higher mortality risk. Compared with 129 mm
Hg, systolic blood pressure values of 107-154 mm
Hg did not significantly predict higher mortality risk.
Before the inflection point of systolic blood pressure
at 129 mm Hg, risk of all cause mortality fell with
increasing systolic blood pressure (hazard ratio 1.47
(95% confidence interval 1.01 to 2.17) at 75 mm Hg,
1.41 (1.03 to 1.93) at 80 mm Hg, 1.29 (1.06 to 1.56)
at 90 mm Hg, 1.16 (1.03 to 1.31) at 100 mm Hg, and
1.08 (1.01 to 1.17) at 106 mm Hg). After the inflection
point, risk of all cause mortality rose with increasing
systolic blood pressure (1.08 (1.01 to 1.17) at 155 mm
Hg, 1.10 (1.01 to 1.20) at 160 mm Hg, 1.15 (1.03 to
1.29) at 170 mm Hg, 1.21 (1.03 to 1.45) at 180 mm Hg,
and 1.27 (1.02 to 1.58) at 190 mm Hg; fig 2).
To compare the ranges of blood pressure with
mortality risk, we analysed Cox proportional hazards
models with the middle range of blood pressure as the
reference category. Compared with the middle range of
systolic blood pressure or pulse pressure values, lower
and higher values were significantly associated with a
greater mortality risk after adjustment (systolic blood
pressure: hazard ratio 1.30 (95% confidence interval
1.11 to 1.53) for lower group, 1.16 (1.02 to 1.30)
for higher group; pulse pressure: 1.13 (1.02 to 1.25)
and 1.15 (1.02 to 1.29); table 2). After conducting
sensitivity analyses, the U shaped associations of
systolic blood pressure and pulse pressure with
mortality remained when participants lost to followup were censored at 1.5 years, all participants lost to
follow-up were removed, or participants who died in
the first year were excluded (table 2).
Association of systolic blood pressure with all cause
mortality in subgroups
We found significant interactions between systolic
blood pressure and age group (octogenarians,
nonagenarians,
and
centenarians,
P<0.001),
comorbidities (P=0.02), functioning in activities of
5
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hazard ratios and 95% confidence intervals for systolic
blood pressure, diastolic blood pressure, mean arterial
pressure, or pulse pressure as categorical variables. We
also implemented Cox models with penalised splines
to assess the associations of continuous systolic blood
pressure with cardiovascular and non-cardiovascular
mortality. Adjusting for the above demographic and
biological covariates, we used Cox proportional
hazards models to assess the association between
categorical systolic blood pressure and cause specific
mortality.
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Characteristics

Sex
Men
Women
Age (year)‡
Education (years)‡
Marital status
In marriage
Not in marriage
Residence
Urban
Rural
Economic income
High
Medium or low
Current smoking practice
Alcohol consumption habits
Cognitive impairment
Restriction on activities of daily living
Poor visual function
Frailty
Robust
Pre-frailty
Frailty
Self reported hypertension history
Body mass index‡
Central obesity
Diabetes mellitus
Cardiovascular disease
Stroke and cerebrovascular disease
Respiratory disease
Cancer
Comorbidity
0
≥1
Systolic blood pressure (mm Hg)‡
Diastolic blood pressure (mm Hg)‡
Mean arterial pressure (mm Hg)‡
Pulse pressure (mm Hg)‡
Systolic blood pressure classification
Lower (<107 mm Hg)
Middle (107-154 mm Hg)
Higher (>154 mm Hg)
Antihypertensive treatment

Decedents (n=1997)

Survivors (n=2414)*

Lost to follow-up (n=247)†

Total (n=4658)

833 (41.7)
1164 (58.3)
94.7 (7.3)
1.5 (3.0)

1052 (43.6)
1362 (56.4)
89.8 (7.0), P<0.01
1.8 (3.2), P<0.01

149 (60.3)
98 (39.7)
93.5 (8.0), P<0.01
2.9 (4.4), P<0.01

1983 (42.6)
2675 (57.4)
92.1 (7.6)
1.8 (3.2)

348 (17.4)
1649 (82.6)

693 (28.7), P<0.01
1721 (71.3)

52 (21.1), P<0.01
195 (78.9)

1093 (23.5)
3565 (76.5)

395 (19.8)
1602 (80.2)

475 (19.7)
1939 (80.3)

134 (54.3), P<0.01
113 (45.7)

1004 (21.5)
3654 (78.5)

307 (15.4)
1690 (84.6)
270 (13.5)
276 (14.0)
1291 (64.7)
1049 (52.5)
782 (39.2)

506 (21.0), P<0.01
1908 (79.0)
421 (17.4), P<0.01
417 (17.3), P<0.01
917 (38.0), P<0.01
617 (25.6), P<0.01
573 (23.7), P<0.01

43 (17.4), P<0.01
204 (82.6)
27 (10.9), P<0.01
36 (14.6)
132 (53.4), P<0.01
119 (48.2), P<0.01
62 (25.1), P<0.01

856 (18.4)
3802 (81.6)
718 (15.4)
731 (15.7)
2340 (50.2)
1785 (38.3)
1417 (30.4)

535 (26.8)
783 (39.2)
679 (34.0)
478 (23.9)
19.8 (3.5)
669 (33.5)
62 (3.1)
244 (12.2)
169 (8.5)
281 (14.1)
18 (0.9)

1219 (50.5), P<0.01
868 (36.0)
327 (13.5)
662 (27.4), P<0.01
20.9 (3.5), P<0.01
1037 (43.0), P<0.01
76 (3.2)
295 (12.2)
146 (6.1), P<0.01
298 (12.3)
17 (0.7)

101 (40.9), P<0.01
79 (32.0)
67 (27.1)
55 (22.2), P<0.01
20.3 (3.6)
106 (43.0), P<0.01
6 (2.4)
43 (17.4), P<0.01
33 (13.4), P<0.05
33 (13.4)
4 (1.6)

1855 (39.8)
1730 (37.1)
1073 (23.1)
1195 (25.7)
20.4 (3.5)
1812 (38.9)
144 (3.1)
582 (12.5)
348 (7.5)
612 (13.1)
39 (0.8)

1385 (69.4)
612 (30.6)
134.3 (21.2)
79.2 (12.2)
97.6 (13.5)
55.0 (17.3)

1762 (73.0), P<0.01
652 (27.0)
136.0 (19.3), P<0.01
79.6 (11.4)
98.4 (12.3), P<0.05
56.4 (16.3), P<0.01

154 (62.4), P<0.01
93 (37.6)
130.6 (19.2)
78.4 (13.7)
95.8 (14.0)
52.2 (15.4)

3301 (70.9)
1357 (29.1)
135.0 (20.2)
79.4 (11.8)
97.9 (12.9)
55.6 (16.7)

176 (8.8)
1484 (74.3)
337 (16.9)
108 (59.3)

118 (4.9), P<0.01
1888 (78.2)
408 (16.9)
72 (45.9), P<0.05

17 (6.9)
201 (81.4)
29 (11.7)
—

311 (6.7)
3573 (76.7)
774 (16.6)
180 (53.1)

*Survivors versus decedents.
†Participants lost to follow-up versus participants successfully followed up.
‡Data reported as the mean (standard deviation) for continuous variables.

daily living (P<0.001), and frailty (P<0.001). We
observed a marginally significant interaction with
self reported hypertension history (P=0.08), and
non-significant interactions with residence (P=0.20)
and marital status (P=0.14). Significant U shaped
associations of systolic blood pressure with three year
all cause mortality were evident for octogenarians
and nonagenarians but not for centenarians. For
centenarians, we found a similar U shaped trend, but it
was not significant (P=0.13), which could be due to the
relatively limited study sample. We observed U shaped
associations of systolic blood pressure with mortality
among participants in both rural and urban areas.
Based on the supplementary phone interview, we
found no association between systolic blood pressure
and mortality according to whether participants were
taking antihypertensive treatment or not.
6

Association of systolic blood pressure with cause
specific mortality
Among 1088 participants with an ascertained cause of
death, 270 (24.8%) died from cardiovascular disease
and 818 (75.2%) died from non-cardiovascular causes.
Cause specific analyses showed linear associations
between systolic blood pressure and cardiovascular
death (P<0.001) and non-cardiovascular death
(P<0.001; fig 3). Each increment of 10 mm Hg in
systolic blood pressure corresponded to an 11%
increase in cardiovascular mortality (adjusted hazard
ratio 1.11 (95% confidence interval 1.05 to 1.18)), and
a 5% decrease in risk of non-cardiovascular mortality
(0.95 (0.92 to 0.99); table 3).
Compared with middle range systolic blood pressure
(107-154 mm Hg), higher values (>154 mm Hg)
predicted a higher risk of cardiovascular mortality
doi: 10.1136/bmj.k2158 | BMJ 2018;361:k2158 | the bmj
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Table 1 | Characteristics of 4658 Chinese oldest old participants according to survival status during three year followup. Data are number (%) of participants unless specified otherwise
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Table 2 | Three year all cause mortality versus different levels of blood pressure, in study population of Chinese oldest old people

Decedents (No)

Systolic blood pressure
Lower (<107 176
mm Hg)
Middle (107- 1484
154 mm Hg)
Higher (>154 337
mm Hg)
Diastolic blood pressure
Lower (<70
367
mm Hg)
Middle (701254
90 mm Hg)
Higher (>90
376
mm Hg)
Mean arterial pressure
Lower (<80
165
mm Hg)
Middle (801041
100 mm Hg)
Higher (>100 791
mm Hg)
Pulse pressure
Lower (<50
810
mm Hg)
Middle (50731
65 mm Hg)
Higher (>65
456
mm Hg)

Hazard ratio (95% CI)

Sensitivity analyses

Mortality rate
(%; 95% CI)

Unadjusted

Adjusted‡

Censoring at 1.5 years
of participants lost to
follow-up

Removal of all
participants lost to
follow-up

Exclusion of
participants who
died in the first year

58.4 (52.6 to 64.2)

1.57 (1.35 to 1.84)†

1.30 (1.11 to 1.53)†

1.27 (1.08 to 1.48)†

1.27 (1.08 to 1.48)†

1.38 (1.14 to 1.67)†

42.9 (41.3 to 44.6)

1.00 (reference)

1.00 (reference)

1.00 (reference)

1.00 (reference)

1.00 (reference)

44.6 (41.0 to 48.1)

1.04 (0.93 to 1.17)

1.16 (1.02 to 1.30)*

1.15 (1.02 to 1.29)*

1.15 (1.02 to 1.29)*

1.17 (1.02 to 1.36)*

48.5 (44.9 to 52.1)

1.17 (1.04 to 1.31)*

1.02 (0.90 to 1.14)

1.04 (0.94 to 1.16)

1.07 (0.96 to 1.19)

0.99 (0.88 to 1.14)

43.3 (41.5 to 45.1)

1.00 (reference)

1.00 (reference)

1.00 (reference)

1.00 (reference)

1.00 (reference)

43.7 (40.3 to 47.1)

1.02 (0.90 to 1.14)

1.01 (0.90 to 1.13)

1.02 (0.91 to 1.15)

1.03 (0.92 to 1.16)

0.96 (0.83 to 1.11)

52.3 (46.5 to 58.1)

1.28 (1.08 to 1.51)†

1.08 (0.89 to 1.30)

1.13 (0.97 to 1.34)

1.13 (0.98 to 1.33)

1.13 (0.92 to 1.40)

46.0 (42.4 to 49.6)

1.00 (reference)

1.00 (reference)

1.00 (reference)

1.00 (reference)

1.00 (reference)

43.9 (41.6 to 46.1)

1.02 (0.93 to 1.11)

1.08 (0.95 to 1.23)

1.07 (0.98 to 1.18)

1.09 (0.99 to 1.19)

1.08 (0.97 to 1.22)

48.3 (45.9 to 50.7)

1.21 (1.10 to 1.34)†

1.13 (1.02 to 1.25)*

1.13 (1.02 to 1.25)*

1.14 (1.03 to 1.26)*

1.14 (1.01 to 1.29)*

41.5 (39.1 to 43.9)

1.00 (reference)

1.00 (reference)

1.00 (reference)

1.00 (reference)

1.00 (reference)

42.2 (39.4 to 45.3)

1.03 (0.92 to 1.16)

1.15 (1.02 to 1.29)*

1.15 (1.02 to 1.29)*

1.14 (1.01 to 1.28)*

1.15 (1.00 to 1.32)*

*P<0.05.
†P<0.01.
‡Cox proportional hazards models were applied, with adjustment for sex, age (as linear term), marital status, educational background (as linear term), residence, economic income, current
smoking, current alcohol consumption, cognitive impairment, restriction on activities of daily living, poor visual function, body mass index (as linear term), central obesity, diabetes mellitus,
cardiovascular disease, stroke and other cerebrovascular diseases, respiratory disease, cancer, and frailty.

(adjusted hazard ratio 1.51 (95% confidence interval
1.12 to 2.02)); lower values (<107 mm Hg) did not
significantly predict cardiovascular mortality risk (0.91
(0.54 to 1.56)). However, lower values predicted a
higher risk of non-cardiovascular mortality (1.58 (1.26
to 1.98)); higher values did not significantly predict
non-cardiovascular mortality risk (0.97 (0.79 to 1.19);
table 3). These results indicated that a higher systolic
blood pressure predicted a higher risk of cardiovascular
mortality, whereas lower values predicted a higher risk of
non-cardiovascular mortality in the study participants.

Discussion
In this community based prospective study, after
adjustment for important identified confounders,
systolic blood pressure presented a U shaped association
with all cause mortality among a group of oldest old
people in China. Specifically, higher values of systolic
blood pressure predicted a higher risk of cardiovascular
mortality; lower values predicted a higher risk of
non-cardiovascular mortality. After we explored this
association in different subgroups of participants, the
results further supported the U shaped association
between systolic blood pressure and mortality.
Comparison with other studies
Individuals older than 80 years have rarely been a
target population for investigating the relations of
the bmj | BMJ 2018;361:k2158 | doi: 10.1136/bmj.k2158

blood pressure with cause specific mortality and all
cause mortality. Previous clinical or epidemiological
studies have reported conflicting results regarding this
association.3-19 Most observational studies have found
that high blood pressure predicted higher mortality
risk,3-11 although some observational studies reported
no relation of blood pressure with mortality.15 16
The findings of the present study has been relatively
similar to those from previous investigations.12-14 In a
three year follow-up of 724 participants aged 84-88
years in Finland, participants with an systolic blood
pressure of 140-169 mm Hg or diastolic blood pressure
of 70-99 mm Hg had the lowest mortality risk.12 A
study of 348 people aged 85 years and older in Sweden
identified a U shaped association of systolic blood
pressure with mortality; after inclusion of systolic
blood pressure as the squared term in the adjusted Cox
regression, the optimal value was found to be 164.2
mm Hg for this age group.13 Among 1088 Americans
aged 85 years and older, higher systolic blood pressure
was found to predict improved survival during a six
year follow-up; a J shaped association was seen after
quadratic transformation of systolic and diastolic
blood pressure.14 However, none of those findings of
a J or U shaped association was based on Cox models
with penalised splines, which were able to examine a
non-parametric (non-linear or linear) association of
blood pressure with mortality.
7
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Variables
and value
groups

organic changes in the cardiovascular system occur in
response to metabolic alterations; those changes could
affect blood pressure. In addition, people who survive
to age 80 could be selected healthy individuals. It is
possible that middle aged or younger elderly people
with low or high blood pressure have a higher mortality
risk; the oldest old individuals in our study could have
been a select population3 as a result of regression to
the mean. In our study, higher systolic blood pressure
predicted a higher risk of cardiovascular mortality, and
lower systolic blood pressure predicted a higher risk
of non-cardiovascular mortality; this finding probably
explains the U shaped association of systolic blood
pressure with all cause mortality.

5.0

2.0
1.0
0.5

Hazard ratio for
non-cardiovascular mortality

0.2
5.0

2.0
1.0
0.5
0.2
60

80

100

120

140

160

180

200

Systolic blood pressure (linear; P<0.001)

Fig 3 | Associations of systolic blood pressure with three
year cardiovascular and non-cardiovascular mortality
risk in study population of Chinese oldest old people,
in Cox models with penalised splines after adjustment.
Lines=estimated hazard ratio of systolic blood pressure
(129 mm Hg reference) for three year cardiovascular
and non-cardiovascular mortality; dotted lines=95%
confidence intervals

Compared with previous studies,12-14 the present
investigation found lower levels of systolic and diastolic
blood pressure in the oldest old study sample. This
difference could have been due to our oversampling
of nonagenarians and centenarians. In this survey,
centenarians, one nearby octogenarian, and one
nearby nonagenarian in each of the selected counties
were interviewed. This sample was therefore different
from a population with a naturally occurring age
distribution, because the participants was relatively
older (92.1 years). Accordingly, our participants could
have had lower blood pressure because blood pressure
declines with age after 75 years.39
The association of blood pressure with mortality
remains unclear. In the ageing process, functional and

Lower blood pressure and mortality
The most likely explanation for increased mortality
risk in participants with lower systolic blood pressure
was chronic disease—eg, cardiovascular disease40
(cardiac failure or ischaemic heart disease), cancer or
other wasting diseases,41 or poor functional status or
frailty.42 The lower values of systolic blood pressure
observed in our participants could be due to increasing
vascular frailty, or related to deteriorating health with
ageing. In previous investigations of participants
aged 85 years and older, the association of lower
blood pressure with greater mortality disappeared
after adjustment for poor health status.43 But in the
present study, the association remained robust even
after controlling for health status or functional status.
In the subgroup analyses, the U shaped association
persisted in participants without comorbidities, in
those who were able to perform activities of daily
living adequately, and in pre-frail participants. These
findings indicated that the association of lower systolic
blood pressure with increased mortality cannot be
entirely explained by chronic illnesses, poor functional
status, or frailty.
The association of lower blood pressure with greater
mortality risk has been shown to be relevant only in
the short term.44 As previous studies have shown,45 46
after exclusion of death in the first year, the relation
between lower systolic blood pressure and increased
mortality risk remained. This finding suggested that
lower systolic blood pressure being predictive of higher
risks of non-cardiovascular mortality and all cause

Table 3 | Three year cause specific mortality versus different levels of systolic blood pressure, in study population of Chinese oldest old people*
Hazard ratio (95% CI)
Variables

Cardiovascular mortality

Non-cardiovascular mortality

All cause mortality

Unadjusted

Adjusted

Unadjusted

Adjusted

Unadjusted

Adjusted

1.11 (1.05 to 1.18)‡

0.91 (0.88 to 0.94)‡

0.95 (0.92 to 0.99)†

0.97 (0.95 to 0.99)‡

1.01 (0.98 to 1.03)

0.91 (0.54 to 1.56)
1.00 (reference)
1.51 (1.12 to 2.02)‡

1.93 (1.55 to 2.41)‡
1.00 (reference)
0.84 (0.69 to 1.03)

1.58 (1.26 to 1.98)‡
1.00 (reference)
0.97 (0.79 to 1.19)

1.57 (1.35 to 1.84)‡
1.00 (reference)
1.04 (0.93 to 1.17)

1.30 (1.11 to 1.53)‡
1.00 (reference)
1.16 (1.02 to 1.30)†

Systolic blood pressure as continuous variable
Each 10 mm Hg increment 1.10 (1.04 to 1.116)‡
Systolic blood pressure as categorical variable
Lower (<107 mm Hg)
0.96 (0.56 to 1.67)
Middle (107-154 mm Hg)
1.00 (reference)
Higher (>154 mm Hg)
1.47 (1.10 to 1.96)‡

*Cox proportional hazards models were applied, with adjustment for sex, age (as linear term), marital status, educational background (as linear term), residence, economic income, current
smoking, current alcohol consumption, cognitive impairment, restriction on activities of daily living, poor visual function, body mass index (as linear term), central obesity, diabetes mellitus,
cardiovascular disease, stroke and other cerebrovascular diseases, respiratory disease, cancer, and frailty.
†P<0.05
‡P<0.01.
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Higher blood pressure and mortality
The evidence for treating patients 80 years and older
has long been debated; epidemiological studies have
detected the association of higher blood pressure with
increased mortality risk for this age group.2-11 In the
present study, compared with a middle value range
of systolic blood pressure, a higher value (>154 mm
Hg) predicted a higher risk of all cause mortality and
cardiovascular mortality, which was in accordance
with other investigations.17 47-50
It has been found that treatment of hypertension
reduced stroke while possibly increasing all cause
mortality.47 A study of 3845 patients older than 80
years in Europe, Australasia, Tunisia, and China
showed a reduction in mortality with hypertension
treatment.48 One large meta-analysis showed that a
high systolic blood pressure predicted a higher risk
of mortality for any age group, including oldest old
people; however, the relation weakened considerably
with ageing.17 Recent guidelines on antihypertensive
treatment for older individuals with hypertension
could be beneficial, including those aged over 80
years.49 50
Associations of mean arterial pressure and pulse
pressure with mortality
The same level of attention to systolic and diastolic
blood pressure has not been given to pulse pressure.
However, studies have suggested that pulse pressure
was more sensitive for mortality predication, with
increased aortic regurgitation or aortic stiffness
with ageing among elderly people aged 65 years
and older.51 52 Very few studies have focused on the
association of mortality with pulse pressure, and those
few studies have found no significant associations in
oldest old people.7 The present investigation showed
that both lower and higher pulse pressure predicted
poor survival, suggesting that pulse pressure—and not
just systolic and diastolic blood pressure—should be
considered in oldest old individuals.
To our knowledge, no previous reports have focused
on the role of mean arterial pressure in oldest old
people—even though studies have revealed that it is
likely to be a more accurate predictor than other blood
pressure indexes.53 Our study showed a U shaped
association of mean arterial pressure with mortality in
Cox models with penalised splines before adjustment;
however, the association was not evident on further
analysis after adjustment.
Strengths and limitations
Our study had a large sample size to assess the role
of blood pressure in all cause mortality and cause
specific mortality among community based oldest
old people in China. This large sample allowed
robust conclusions to be drawn with respect to
octogenarians, nonagenarians, and centenarians. This
study performed Cox models with penalised splines to
the bmj | BMJ 2018;361:k2158 | doi: 10.1136/bmj.k2158

investigate potential non-linear associations, and our
methodology allowed the optimal blood pressure to be
identified. This study also focused on the association
of mean arterial pressure with mortality among oldest
old individuals. Furthermore, the study participation
rate was very high (94.7%), indicating that obtaining
death information was relatively complete.
This study had several limitations. Firstly, no
corrections were conducted in multiple comparisons,
which could have increased the possibility of type 1
errors. However, the U shaped association might be a
true association because it was consistently detected
for systolic blood pressure and pulse pressure after
adjustment. Secondly, blood pressure in this study was
measured at one time only; however, the variability
between the two blood pressure measurements at
baseline was small. Thirdly, most of the clinical
diseases adjusted as confounding factors were self
reported; participants were asked whether diseases
had been diagnosed by a doctor. Furthermore, we
obtained information on cause specific death for only
54% of decedents. It was difficult to determine the
cause of death for people aged 80 years and older,
who were likely to have various chronic diseases—
especially among those who died at home and not in
hospital. Finally, this study included only people aged
80 years and older; the findings cannot therefore be
generalised to younger populations.

Conclusions
In this longitudinal, community based prospective
study among oldest old people in China, systolic blood
pressure showed a U shaped association with three
year all cause mortality. This association is likely to be
explained by the finding that higher values of systolic
blood pressure predicted a higher risk of cardiovascular
mortality, and lower values of systolic blood pressure
predicted a higher risk of non-cardiovascular mortality.
The present paradigm of “the lower the better” in
blood pressure regulation does not apply to oldest old
people; practitioners and researchers should be aware
that the notion of so-called normal blood pressure
might need to be revisited after age 80 years. Present
guidelines for blood pressure management have been
proposed to be applied individually and cautiously
with this population. Specific guidelines might need
to be explored for blood pressure management for
individuals older than 80 years with different blood
pressure levels.
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mortality was more complex than a simple fall in blood
pressure approaching death.
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